Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.
Moses BS, McCullough S, Fox JM, Mott BT, Bentzen SM, Kim M, Tyner JW, Lapidus RG, Emadi A, Rudek MA, Kingsbury TJ, Civin CI.
Moses BS, et al. Among authors: mott bt.
Blood Adv. 2021 Feb 9;5(3):711-724. doi: 10.1182/bloodadvances.2020003429.
Blood Adv. 2021.
PMID: 33560385
Free PMC article.